2020
DOI: 10.5853/jos.2020.00556
|View full text |Cite
|
Sign up to set email alerts
|

Five-Year Cumulative Cost Saving with Thrombolysis in Korea: 3-Month Disability-Based Estimation

Abstract: has received lecture honoraria and research grants from Boehringer Ingelheim Korea related to the current topic. Dr. Hee-Joon Bae was involved as a site investigator of a multicenter clinical trial sponsored by Boehringer Ingelheim.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 8 publications
0
1
0
Order By: Relevance
“…25 26 While outcomes after stroke can be difficult to predict, 27 efforts to prevent accumulated disability are likely to be highly cost-effective given reductions in morbidity, nursing requirements, and long-term costs after stroke, in addition to quality of life benefits. [28][29][30][31][32] Indeed, growing evidence supports the importance of patients' perspectives on quality of life. 33 Further evaluations investigating these additional outcomes are warranted.…”
Section: Discussionmentioning
confidence: 99%
“…25 26 While outcomes after stroke can be difficult to predict, 27 efforts to prevent accumulated disability are likely to be highly cost-effective given reductions in morbidity, nursing requirements, and long-term costs after stroke, in addition to quality of life benefits. [28][29][30][31][32] Indeed, growing evidence supports the importance of patients' perspectives on quality of life. 33 Further evaluations investigating these additional outcomes are warranted.…”
Section: Discussionmentioning
confidence: 99%